Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry. In today’s Pharmaceutical Executive Daily, ...

Chakravarthi AVPS, Chairman of the Federation of Pharma Entrepreneurs, provides an overview of global strategies to accelerate access to innovative therapies, bridging equity, regulation, and ...

Karthik Sankaranarayanan trained in two quite different scientific subfields as a graduate student and as a postdoctoral ...

In this monthly news roundup, we take a look back at top moments from the pharmaceutical industry. It’s time to reflect on ...

As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...

Pharmaceutical companies are boosting their spending on lobbying firms with connections to the White House ...

The global pharmaceuticals market is estimated to reach $1.21 trillion in 2025, according to Statista data. Overall, Statista predicted the worldwide pharma industry market revenue will increase 4.5% ...

In February 2025, authorities approved a national programme to develop the pharmaceutical and chemical industry through 2030, with a longer-term vision to 2045.

Clawbacks, discontinued therapies, delays, lay-offs and disinvestment have created a concerning pharma business environment in Greece, industry has warned ...

Pharmexcil warns that global freight market challenges could lead to ₹5,000 crore losses for Indian pharma exports.

U.S. President Donald Trump, on Tuesday, disclosed plans for a "major tariff" on foreign pharmaceuticals. "We're going to be announcing very shortly a major tariff on pharmaceuticals… when they hear ...

The pharma industry in the country has indicated readiness to target double-digit growth in 2026–27, said the ministry of commerce and industry. This was discussed in a Chintan Shivir, an industry ...